PKPD Bioscience will help support your strategic drug development decisions and new drug approvals through quantitative analysis and predictive models of diseases, drugs and clinical trials.
For more than 10 years, our scientists have provided a unique combination of insight and innovation building quantitative models of diseases, drugs (PK/PD) and clinical trials. Once developed, the value of these integrated models comes in using them to design, test and explore various untested clinical scenarios through computer-based simulation. Our core offerings and expertise support dose selection, trial design, labeling and strategic program decisions (e.g., go/no-go).
The benefits of quantitative drug-disease-trial modeling and simulation have been well demonstrated by FDA and industry sponsors. Contact us today to see how we can help you achieve tangible benefits for your development programs, such as:
- Getting the dose right
- Designing fewer, smaller, more efficient clinical trials
- Improving interactions with regulatory authorities
- Developing therapeutics with better benefit/risk profiles
- Attracting investor funding or securing a development partner